Vitespen Completed Phase 2 Trials for Lung Cancers / Pulmonary Cancer / Lung Cancer Non-Small Cell Cancer (NSCLC)

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00098085Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer